LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 113 filers reported holding LEXICON PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $110 | -55.8% | 100,691 | -7.1% | 0.00% | – |
| Q2 2023 | $249 | -34.6% | 108,386 | -30.8% | 0.00% | – |
| Q1 2023 | $381 | +2.7% | 156,621 | -19.3% | 0.00% | – |
| Q4 2022 | $371 | -99.9% | 194,113 | +0.4% | 0.00% | – |
| Q3 2022 | $464,000 | +26.4% | 193,275 | -2.1% | 0.00% | – |
| Q2 2022 | $367,000 | +14.0% | 197,441 | +28.3% | 0.00% | – |
| Q1 2022 | $322,000 | -43.1% | 153,932 | +7.2% | 0.00% | – |
| Q4 2021 | $566,000 | -9.1% | 143,632 | +10.9% | 0.00% | – |
| Q3 2021 | $623,000 | +4.7% | 129,568 | 0.0% | 0.00% | – |
| Q2 2021 | $595,000 | -1.5% | 129,568 | +25.9% | 0.00% | – |
| Q1 2021 | $604,000 | -1.9% | 102,931 | -42.8% | 0.00% | – |
| Q4 2020 | $616,000 | +26.7% | 180,075 | -46.6% | 0.00% | – |
| Q3 2020 | $486,000 | -27.8% | 337,375 | 0.0% | 0.00% | – |
| Q2 2020 | $673,000 | +50.9% | 337,375 | +47.7% | 0.00% | – |
| Q1 2020 | $446,000 | -44.5% | 228,475 | +18.2% | 0.00% | – |
| Q4 2019 | $803,000 | +331.7% | 193,375 | +212.8% | 0.00% | – |
| Q3 2019 | $186,000 | -52.1% | 61,830 | +0.3% | 0.00% | – |
| Q2 2019 | $388,000 | +101.0% | 61,642 | +77.4% | 0.00% | – |
| Q1 2019 | $193,000 | -14.2% | 34,742 | +2.4% | 0.00% | – |
| Q4 2018 | $225,000 | -37.0% | 33,942 | +1.4% | 0.00% | – |
| Q3 2018 | $357,000 | -11.4% | 33,466 | -0.4% | 0.00% | – |
| Q2 2018 | $403,000 | +40.4% | 33,607 | +0.4% | 0.00% | – |
| Q1 2018 | $287,000 | -12.5% | 33,460 | +0.9% | 0.00% | – |
| Q4 2017 | $328,000 | -50.3% | 33,176 | -38.3% | 0.00% | – |
| Q3 2017 | $660,000 | +21.1% | 53,736 | +62.2% | 0.00% | – |
| Q2 2017 | $545,000 | +14.7% | 33,136 | 0.0% | 0.00% | – |
| Q1 2017 | $475,000 | +3.7% | 33,136 | +0.1% | 0.00% | – |
| Q4 2016 | $458,000 | -23.4% | 33,119 | 0.0% | 0.00% | – |
| Q3 2016 | $598,000 | -17.9% | 33,119 | -34.7% | 0.00% | – |
| Q2 2016 | $728,000 | +24.0% | 50,719 | +3.3% | 0.00% | – |
| Q1 2016 | $587,000 | +84.0% | 49,099 | +104.6% | 0.00% | – |
| Q4 2015 | $319,000 | 0.0% | 23,999 | -19.2% | 0.00% | – |
| Q3 2015 | $319,000 | +66.1% | 29,699 | +24.8% | 0.00% | – |
| Q2 2015 | $192,000 | – | 23,799 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $37,033,000 | 100.00% |
| Artal Group S.A. | 58,274,650 | $499,413,000 | 6.25% |
| SECTOR GAMMA AS | 854,592 | $7,324,000 | 1.32% |
| NEA Management Company, LLC | 2,382,286 | $20,416,000 | 0.91% |
| Virtus ETF Advisers LLC | 89,845 | $770,000 | 0.67% |
| Malaga Cove Capital, LLC | 59,701 | $512,000 | 0.28% |
| MARSHALL WACE, LLP | 736,545 | $6,312,000 | 0.26% |
| USS Investment Management Ltd | 2,741,942 | $22,607,000 | 0.25% |
| CLEARBRIDGE, LLC | 1,172,117 | $10,045,000 | 0.22% |
| WEDBUSH SECURITIES INC | 155,396 | $1,332,000 | 0.17% |